09 January 2002
Comparative study of early Lyme disease: Erythema migrans in New York State and Northeastern Poland.
Teresa Hermanowska-Szpakowicz, Patricia Coyle, Joanna Zajkowska, Jolanta Ostrowska, Slawomir Pancewicz, Maciej KondrusikMed Sci Monit 2002; 8(1): CR37-43 :: ID: 420965
Abstract
BACKGROUND: The objective was to compare the clinical features of earlylocal Lyme Disease: Erythema Migrans (EM) between two highly endemic areas: New York State and NortheasternPoland. Study was based on self reporting questionnaires, physical examination, and laboratory results.MATERIAL/METHODS: Group I (n=27) consisted of citizens from New York State presenting with EM, referredto the study by their physicians. Group II (n=25) consisted of patients treated as outpatients in 1998-1999at the Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Poland.The diagnosis of EM was based on patient history and clinical picture. RESULTS: Depending on the immunereaction of the host, the clinical picture is variable. The initial symptoms range from discrete to stronglyexpressed. The inflammatory reaction at the site of tick-bite seems to be milder in Europe than in NorthAmerica, which is reflected in the prevalence of the annular form of rash and milder expression of generalsymptoms. Mild or absent general symptoms and the prevalence of the annular over homogenous form areobserved in those areas of Europe where Ixodes ricinus is the main vector. In the endemic area of NewYork State, where Ixodes scapularis mainly occurs, uniform EM with flu-like symptoms is more common.CONCLUSIONS: There are distinct differences in the typical clinical pictures between the two separatedendemic areas of New York State and Northeastern Poland, due to different vectors (saliva components?),bacterial genospecies, likely intermediate hosts and climatic differences. Familiarity with the presentingform of the disease can be very important, especially for primary care physicians.
Keywords: Comparative Study, Erythema, Lyme Disease, New York, Poland, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952